comparemela.com
Home
Live Updates
UPDATE: Sio Gene Therapies to Present New Data at the : comparemela.com
UPDATE: Sio Gene Therapies to Present New Data at the
Oral presentation to discuss new data updates from the high- and low-dose cohorts from the ongoing Phase 1/2 trial of AXO-AAV-GM1 for the treatment of GM1...
Related Keywords
Paragv Meswani ,
Tay Sachs Sandhoff ,
Josephine Belluardo ,
Toloo Taghian ,
Gavin Corcoran ,
Exchange Commission On ,
University Of Massachusetts Medical School ,
Drug Administration ,
Sio Gene Therapies Inc ,
Nasdaq ,
University Of Massachusetts ,
Exchange Commission ,
European Society Of Gene Cell Therapy ,
Lifesci Communications ,
Clinical Development At Sio Gene Therapies ,
Virtual Congress ,
Gene Therapies ,
European Society ,
Cell Therapy ,
Presentation Details ,
Erica De Boever ,
Vice President ,
Clinical Development ,
Sio Gene ,
Thursday October ,
Sandhoff Diseases ,
Dose Evaluation Study ,
Tolerability Data ,
Chief Rd Officer ,
Orphan Drug Designation ,
Rare Pediatric Disease Designation ,
Massachusetts Medical School ,
Private Securities Litigation Reform Act ,
Quarterly Report ,
Nasdaq Siox ,
Sio Gene Therapies ,
comparemela.com © 2020. All Rights Reserved.